Skin Cancer Diagnostics Market Forecast to 2028

Report Code : TIPRE00018116 | Region : Global | Industry : Pharmaceuticals | Published Date : 25/Feb/2022
Skin Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Melanoma and Non-melanoma), Screening Type (Blood Tests, Dermatoscopy, Imaging Tests, Lymph Node Biopsy, and Skin Biopsy)

The skin cancer diagnostics market is projected to reach US$ US$ 5,480.45 million by 2028 from US$ 3,364.46 million in 2021; it is estimated to grow at a CAGR of 7.2% during 2021–2028. The report highlights trends prevailing in the market and factors driving its growth. The market's growth is attributed to the increasing incidence of skin cancer and launch of new products. However, the barriers to early skin cancer diagnostics in low and middle-income countries hampers the market growth.

The surge in awareness is primarily attributed to the support provided by various governments through awareness and prevention campaigns. The Centers for Disease Control and Prevention (CDC) and its partners conduct monitoring of skin cancer cases, their research, provide education, and interventions for skin cancer. The monitoring is achieved through national surveys—such as the Youth Risk Behavior Surveillance System and National Health Interview Survey. These surveys assist in assessing the prevalence of sunburn and sun-protective behaviors to help prevent skin cancer. Countries such as the UK and the Netherlands have also taken initiatives for promoting the early diagnosis of skin cancer. In 2007, the Early Diagnostics Program was initiated at Cancer Research UK, as part of the National Awareness and Early Diagnosis Initiative (NAEDI) for England. Similarly, in July 2011, the Skin Cancer Prevention Strategy and Action Plan (2011–2021) was launched in Northern Ireland, with a major focus on the prevention and early detection of skin cancer in the region. Thus, governments’ efforts to control mortalities associated with skin cancer are likely to provide significant opportunities to the skin cancer diagnostics market players in the coming years.

Based on type, the global skin cancer diagnostics market has been segmented into melanoma and non-melanoma. The non-melanoma segment held the largest share of the market in 2021 and is anticipated to register highest CAGR in the market during the forecast period. Based on screening type, the market is segmented into blood tests, dermatoscopy, imaging tests, lymph node biopsy, and skin biopsy. The skin biopsy segment held the largest share of the market in 2021 and is anticipated to register a high CAGR in the market during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the skin cancer diagnostics market are the National Center for Health Statistics, Indian Council of Medical Research, Centers for Disease Control and Prevention (CDC), the National Center for Biotechnology Information (NCBI), and World Health Organization.

The List of Companies - Skin Cancer Diagnostics Market

1. SkylineDx BV

2. AMLo Biosciences Limited

3. NeraCare GmbH

4. DermLite LLC

5. bioMerieux SA

6. Veriskin Inc.

7. Castle Biosciences, Inc.

8. DermTech Inc.

9. HOFFMANN-LA ROCHE LTD.

10. Michelson Diagnostics Ltd

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Skin Cancer Diagnostics Market – By Type

1.3.2 Global Skin Cancer Diagnostics Market – By Screening Type

1.3.3 Global Skin Cancer Diagnostics Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Skin Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America– PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific– PEST Analysis

4.2.4 Middle East and Africa– PEST Analysis

4.2.5 South and Central America– PEST Analysis

4.3 Expert Opinion

5. Skin Cancer Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidence of Skin Cancer

5.1.2 Launch of New Products

5.2 Market Restraints

5.2.1 Barriers to Early Skin Cancer Diagnostics in Low and Middle-Income Countries

5.3 Market Opportunities

5.3.1 Government Support for Early Skin Cancer Diagnosis

5.4 Future Trends

5.4.1 Skin Cancer Diagnostics Through AI

5.5 Impact Analysis

6. Skin Cancer Diagnostics Market – Global Analysis

6.1 Global Skin Cancer Diagnostics Market Revenue Forecast and Analysis

6.2 Global Skin Cancer Diagnostics Market Revenue Forecast and Analysis

6.3 Market Positioning of Key Players

7. Skin Cancer Diagnostics Market Analysis – By Type

7.1 Overview

7.2 Skin Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)

7.3 Melanoma

7.3.1 Overview

7.3.2 Melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Non-melanoma

7.4.1 Overview

7.4.2 Non-melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Skin Cancer Diagnostics Market – By Screening Type

8.1 Overview

8.2 Skin Cancer Diagnostics Market, by Screening Type, 2021 and 2028 (%)

8.3 Blood Tests

8.3.1 Overview

8.3.2 Blood Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Dermatoscopy

8.4.1 Overview

8.4.2 Dermatoscopy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Imaging Tests

8.5.1 Overview

8.5.2 Imaging Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Lymph Node Biopsy

8.6.1 Overview

8.6.2 Lymph Node Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Skin Biopsy

8.7.1 Overview

8.7.2 Skin Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Skin Cancer Diagnostics Market – Regional Analysis

9.1 North America: Skin Cancer Diagnostics Market

9.1.1 Overview

9.1.2 North America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.3 North America: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.1.4 North America: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ Million)

9.1.5 North America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

9.1.5.1 US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.1.1 US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.1.2 US: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.1.5.1.3 US: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.1.5.2 Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.2.1 Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.2.2 Canada: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.1.5.2.3 Canada: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.1.5.3 Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.3.1 Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.5.3.2 Mexico: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.1.5.3.3 Mexico: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.2 Europe: Skin Cancer Diagnostics Market

9.2.1 Overview

9.2.2 Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.3 Europe: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.2.4 Europe: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.2.5 Europe: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

9.2.5.1 Germany: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.1 Overview

9.2.5.1.2 Germany: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.3 Germany: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.2.5.1.4 Germany: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.2.5.2 United Kingdom: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.1 Overview

9.2.5.2.2 United Kingdom: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.3 United Kingdom: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.2.5.2.4 United Kingdom: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.2.5.3 France: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.1 Overview

9.2.5.3.2 France: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.3 France: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.2.5.3.4 France: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.2.5.4 Italy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.1 Overview

9.2.5.4.2 Italy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.3 Italy: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.2.5.4.4 Italy: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.2.5.5 Spain: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.1 Overview

9.2.5.5.2 Spain: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.3 Spain: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.2.5.5.4 Spain: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.2.5.6 Rest of Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.1 Overview

9.2.5.6.2 Rest of Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.3 Rest of Europe: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.2.5.6.4 Rest of Europe: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.3 Asia Pacific Skin Cancer Diagnostics Market Revenue and Forecasts To 2028

9.3.1 Overview

9.3.2 Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.3 Asia-Pacific: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.3.4 Asia-Pacific: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.3.5 Asia-Pacific: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

9.3.5.1 China: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.1.1 Overview

9.3.5.1.2 China: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ MILLION)

9.3.5.1.3 China: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.3.5.1.4 China: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.3.5.2 Japan: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ MILLION)

9.3.5.2.1 Overview

9.3.5.2.2 Japan: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.2.3 Japan: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.3.5.2.4 Japan: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.3.5.3 India: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.3.1 Overview

9.3.5.3.2 India: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.3.3 India: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.3.5.3.4 India: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.3.5.4 South Korea: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.4.1 Overview

9.3.5.4.2 South Korea: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.4.3 South Korea: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.3.5.4.4 South Korea: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.3.5.5 Australia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.5.1 Overview

9.3.5.5.2 Australia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.5.3 Australia: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.3.5.5.4 Australia: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.3.5.6 Rest of Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.1 Overview

9.3.5.6.2 Rest of Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.3 Rest of Asia-Pacific: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)

9.3.5.6.4 Rest of Asia-Pacific: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)

9.4 Middle East and Africa: Skin Cancer Diagnostics Market

9.4.1 Overview

9.4.2 Middle East and Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.4.3 Middle East and Africa: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.4.4 Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ Million)

9.4.5 Middle East and Africa: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

9.4.5.1 UAE: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.4.5.1.1 UAE: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.4.5.1.2 UAE: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.4.5.1.3 UAE: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.4.5.2 Saudi Arabia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.4.5.2.1 Saudi Arabia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.4.5.2.2 Saudi Arabia: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.4.5.2.3 Saudi Arabia: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.4.5.3 South Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.4.5.3.1 South Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.4.5.3.2 South Africa: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.4.5.3.3 South Africa: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.4.5.4 Rest of Middle East and Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.4.5.4.1 Rest of Middle East and Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.4.5.4.2 Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.4.5.4.3 Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.5 South and Central America: Skin Cancer Diagnostics Market

9.5.1 Overview

9.5.2 South and Central America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.5.3 South and Central America: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.5.4 South and Central America: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ Million)

9.5.5 South and Central America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

9.5.5.1 Brazil: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.5.5.1.1 Brazil: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.5.5.1.2 Brazil: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.5.5.1.3 Brazil: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.5.5.2 Argentina: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.5.5.2.1 Argentina: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.5.5.2.2 Argentina: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.5.5.2.3 Argentina: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

9.5.5.3 Rest of South and Central America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.5.5.3.1 Rest of South and Central America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.5.5.3.2 Rest of South and Central America: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

9.5.5.3.3 Rest of South and Central America: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)

10. Impact of COVID-19 Pandemic on Global Skin Cancer Diagnostics Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact Assessment of COVID-19 Pandemic

10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Skin Cancer Diagnostic Market–Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Skin Cancer Diagnostic Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 SkylineDx BV

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 SWOT Analysis

12.1.5 Key Developments

12.2 AMLo Biosciences Limited

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 SWOT Analysis

12.2.5 Key Developments

12.3 NeraCare GmbH

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 SWOT Analysis

12.3.5 Key Developments

12.4 DermLite LLC

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 bioMerieux SA

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Veriskin Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Castle Biosciences, Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 DermTech Inc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 HOFFMANN-LA ROCHE LTD.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.10 Michelson Diagnostics Ltd.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2. North America: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. US: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4. US: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5. Canada: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6. Canada: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7. Mexico: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8. Mexico: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9. Europe Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. Europe Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 11. Germany Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12. Germany Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 13. United Kingdom Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 14. United Kingdom Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 15. France Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 16. France Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 17. Italy Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 19. Spain Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 20. Spain Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 21. Rest of Europe Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Europe Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 23. Asia-Pacific Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 24. Asia-Pacific Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 25. China Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 26. China Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 27. Japan Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 28. Japan Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 29. India Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 30. India Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 31. South Korea Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 32. South Korea Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 33. Australia Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 34. Australia Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 35. Rest of Asia-Pacific Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 36. Rest of Asia-Pacific Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)

Table 37. Middle East and Africa: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 38. Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ Million)

Table 39. UAE: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 40. UAE: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 41. Saudi Arabia: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 42. Saudi Arabia: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 43. South Africa: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 44. South Africa: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 45. Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 46. Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 47. South and Central America: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 48. South and Central America: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ Million)

Table 49. Brazil: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 50. Brazil: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 51. Argentina: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 52. Argentina: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 53. Rest of South and Central America: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 54. Rest of South and Central America: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 1. Organic Developments in the Skin Cancer Diagnostic Market

Table 2. Inorganic Developments in the Skin Cancer Diagnostics Market

Table 3. Glossary of Terms, Skin Cancer Diagnostics Market

Table 4. Acronym

The List of Companies - Skin Cancer Diagnostics Market

1. SkylineDx BV

2. AMLo Biosciences Limited

3. NeraCare GmbH

4. DermLite LLC

5. bioMerieux SA

6. Veriskin Inc.

7. Castle Biosciences, Inc.

8. DermTech Inc.

9. HOFFMANN-LA ROCHE LTD.

10. Michelson Diagnostics Ltd

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global skin cancer diagnostics market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global skin cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Skin Cancer Diagnostics Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry